Esperion (ESPR)

Company Description

Esperion is a late-stage pharmaceutical company passionately committed to developing and commercializing complementary, once-daily, oral therapies to lower levels of low density lipoprotein (LDL) cholesterol for patients with hypercholesterolemia not adequately treated with current lipid-modifying therapies. Bempedoic acid, a convenient, complementary, cost-effective, once-daily, oral inhibitor of ATP Citrate Lyase (ACLi) brings a targeted mechanism of action to address patients unmet medical needs in a way that is “patient-friendly, physician-friendly, and payer-friendly”.

COMPANY ADDRESS
3891 Ranchero Drive
Suite 150
Ann Arbor, MI 48108

COMPANY PHONE
734-887-3903

COMPANY WEBSITE



Get BioInvest's perspective on Esperion's CEO


Latest Company News

Esperion Therapeutics, Inc. (ESPR) Is Rising But Watch The Charts And Be Careful USA Commerce Daily - 7 hours ago With all other things going on, Esperion Therapeutics, Inc. (NASDAQ:ESPR) has been on a run - rising 200.82 percent in just three months. [...]
Fri, Mar 24, 2017 5:52:00 PM, Continue reading at the source
Price Alert: Esperion Therapeutics Inc (NASDAQ:ESPR) Stock Nears Resistance ... CML News - 10 hours ago Price Alert: Esperion Therapeutics Inc (NASDAQ:ESPR) has now crossed into technical strength -- watch the technical oscillators for momentum gaps. [...]
Fri, Mar 24, 2017 3:00:00 PM, Continue reading at the source
The Esperion Therapeutics' (ESPR) Hold Rating Reaffirmed at JPMorgan Chase & Co. Petro Global News 24 - 16 hours ago JPMorgan Chase & Co. restated their hold rating on shares of Esperion Therapeutics Inc (NASDAQ:ESPR) in a research note issued to investors on Monday morning. Traders Secrets on Esperion Therapeutics, Inc. (ESPR), Staples, Inc. (SPLS) - StockNewsJournal Esperion Therapeutics Inc. (ESPR) Moves Lower on Volume Spike for March 22 - Equities.com [...]
Fri, Mar 24, 2017 9:22:00 AM, Continue reading at the source
Insider Trading Activity Esperion Therapeutics Inc (NASDAQ:ESPR) – Director ... Market Exclusive - 22 hours ago On 7/1/2013 Timothy M Mayleben, CEO, bought 5,000 with an average share price of $14.00 per share and the total transaction amounting to $70,000.00. [...]
Fri, Mar 24, 2017 3:21:00 AM, Continue reading at the source
Looking at the Tea Leaves for Esperion Therapeutics, Inc. (ESPR) The USA Commerce - Mar 22, 2017 We have gathered the technical data on Esperion Therapeutics, Inc. (ESPR), and see some interesting trends in the stock's behavior of late. [...]
Wed, Mar 22, 2017 6:11:00 PM, Continue reading at the source
Esperion Therapeutics Inc. (ESPR) Breaks into New 52-Week High on March 20 Session Equities.com - Mar 20, 2017 Shares of Esperion Therapeutics Inc. (ESPR) broke into a new 52-week high yesterday, hitting a peak of $42.59. Shares closed at $41.22 after opening at $32.10 for a move of 74.14%. [...]
Mon, Mar 20, 2017 9:30:00 PM, Continue reading at the source
Esperion Therapeutics stock surges 52% after it says the FDA gave its drug ... MarketWatch - Mar 20, 2017 Esperion Therapeutics Inc. ESPR, +3.56% shares surged 52.0% in morning trade Monday after the company said the Food and Drug Administration gave it positive feedback on a cholesterol-lowering drug, saying that the late-stage program is enough to ... Esperion Therapeutics Rockets 70% Higher After Big Selloff - Benzinga [...]
Mon, Mar 20, 2017 3:01:00 PM, Continue reading at the source
Esperion Therapeutics Inc. (ESPR) Plunges 6.17% on March 16 Equities.com - Mar 16, 2017 Esperion Therapeutics Inc. (ESPR) had a rough trading day for Thursday March 16 as shares tumbled 6.17%, or a loss of $-1.95 per share, to close at $29.65. Esperion Therapeutics (ESPR) Reaches $23.23 After 6.00% Down Move, Gap (GPS ... - Herald KS Esperion Therapeutics, Inc. (NASDAQ:ESPR) Tumbles -25.83% in Pre-Market - Benchmark Monitor [...]
Thu, Mar 16, 2017 9:30:00 PM, Continue reading at the source
Esperion Therapeutics (ESPR) Jumps: Stock Moves Up 8.6% Yahoo Finance - Mar 9, 2017 Esperion Therapeutics, Inc. ESPR was a big mover last session, as its shares rose above 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. [...]
Thu, Mar 09, 2017 1:56:00 PM, Continue reading at the source
Esperion Therapeutics (ESPR) Jumps: Stock Moves Up 8.6% March 09, 2017 Zacks.com - Mar 9, 2017 Esperion Therapeutics, Inc. (ESPR - Free Report) was a big mover last session, as its shares rose above 8% on the day. [...]
Thu, Mar 09, 2017 12:11:00 PM, Continue reading at the source